期刊文献+

血管内皮细胞损伤的分子标志物与糖尿病血管病变 被引量:10

在线阅读 下载PDF
导出
摘要 血管内皮细胞损伤不但促进大血管病变还促进微血管病变的发生发展。血浆可溶性内皮细胞蛋白C受体、血栓调节蛋白、血管性假性血友病因子不但可作为血管内皮细胞损伤的标志物及药物干预治疗的有用指标 ,且参与了血管病变的发生和发展。测定上述分子标志物可以早期反映血管内皮细胞损伤及其程度 。
出处 《国外医学(内科学分册)》 2004年第7期300-302,307,共4页 Foreign Medical Sciences(Section of Internal Medicine)
  • 相关文献

参考文献25

  • 1Taylor FB, Peer GT, Lockart MS, et al. [J].Blood ,2002,97 ( 6 ) : 16585-16588.
  • 2Van de Water NS, French JK, McDowell J, et al.[J]. Thromb Haemost,2001,85(4) :745-751.
  • 3Kurosawa S, Stearns-Kurosawa D J, Hidari N, et al.[J]. J Clin lnvest,1997,100(2):411.
  • 4Biguzzi E,Merati G,Patricia C,et al. [J]. Thromb Haemost ,2001,86 (4) : 945-948.
  • 5Esmon CT. [J]. Bailliere Best Praet Res Chin Haematol, 1999,12 ( 3 ) : 343-359.
  • 6Laszik Z,Mitro A,Taylor FB,et al. [J]. Circulation, 1999,96:3622.
  • 7Fukudome K, Ye X, Tsuneyoshi N, et al. [J]. J Exp Med, 1998,187 : 1029-1035.
  • 8Dekert T, Kofod EA, Norgaard K, et al. [ J ]. Diabetes Care, 1992,15(9) : 1181-1188.
  • 9叶山东,李素梅,周志中,吴竞生,陈超,陈若平,莫蔚林.2型糖尿病患者血浆可溶性内皮细胞蛋白C受体和血栓调节蛋白的变化[J].中国实验诊断学,2001,5(6):304-306. 被引量:6
  • 10Kessler L, Wiesel ML,Attali P,et al. [J]. Diabetes Metab, 1998,24(4) :327-336.

二级参考文献11

  • 1[1]Esmon CT, Xn J, Gu JM, et al. Endothelial protein C receptor[J]. Thorm Haemost, 1999, 82 (2) :251.
  • 2[2]Stearns-Kurosawa DJ, Kurosawa S, Mollica JS, et al. The endothelial cell protein C receptor augments protein C activation by the thrombinthrombomodulin complex[J]. Proc Natl Acad Sci USA, 1996, 93:10212.
  • 3[3]Aso Y, Inukai T, Takenura Y, et al. Mechanisms of elavation of serum and urinary concentrations of soluble thrombomodulin in diabetic patients: possible application as a marker for vascular endothelial injury [J]. Metabolism, 1998, 47: 362.
  • 4[4]Takahashi HS, Ito M, Hanano K, et al. Circulating thrombomodulin as a novel endothelial cell maker: comparison of its behavior with yon Wlllebrand factor and tissure-type plasminogen activator [J ]. Am J Hermatol, 1992, 41: 32.
  • 5[5]Waugh JM, Yuksel E, Li J. Local overexpression of thrombomodulin for in vivo prevention of arterial thrombosis in a rabbit model[J]. CircRes, 1999, 84(1): 84.
  • 6[6]Laszik Z, Mitro A, Taylor FB, et al. Hunmn protein C receptor is present primmrily on endotheliurm of large blood vessels: implications for the control of the protein C pathway[J]. Circulation, 1997, 96: 3622.
  • 7[7]Ye X, Fukudome K, Tsuneyoshi N. The endothelial cell protein C receptor (EPCR) functions as a primary receptor for protein C activation on endothelial cells in arteries, veins, and capillaries[J]. Biochem Biophys Res Commum, 1999, 259(3): 671.
  • 8[8]Fukudome K, Esmon CT. Identificating, cloning and regulation of a novel endothelial cell protein C/activated protein C receptor[J ]. J Biol Chem, 1994, 269:2648
  • 9[9]Kurosawa S, Steams-Kurosawa DJ, Hidari N, et al. Identification of functional endothelial protein C receptor in human plasma[J]. J Clin Invest, 1997, 100(2): 411.
  • 10[10]Dekert T, Kofod EA, Norgaard K, et al. Microalbuminuria: implications for micro- and marco-vascular disease[J]. Diabetes Care, 1992; 15(9):1181.

共引文献5

同被引文献71

引证文献10

二级引证文献64

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部